Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

House Commerce Committee expected to mark up FDA reform legislation by mid-July.

This article was originally published in The Gray Sheet

Executive Summary

HOUSE COMMERCE FDA REFORM LEGISLATION EXPECTED TO BE MARKED UP BY MID-JULY, with the goal of securing passage by the House and completing conference negotiations with the Senate before Congress' August recess begins on Aug. 2. Sen. James Jeffords' (R-Vt.) FDA reform legislation was reported out of the Labor and Human Resources Committee June 18 ("The Gray Sheet" June 23, p. 8).
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT008306

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel